Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Clinical Trial

<< Previous

Bullboard Posts

Next >>

Comment by BlueFrankyon Jul 12, 2023 2:05pm

171 Views

Post# 35537825

RE:RE:RE:RE:RE:RE: RE: Clinical Trial

Like your thinking Eog..

What we miss on the swing, we would more than make up for on the merry-go-round by attracting eyes and ears on all fronts, hastening the trial completion.. improving our numbers exponentially along the way..

...with several jockeys increasingly focused on this "one and done" dark horse ;-)

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China